Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Varicella Zoster Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06806137
What this trial is testing

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

Who this might be right for
Chickenpox
GlaxoSmithKline 600
Testing effectiveness (Phase 2)Study completedNCT00487682
What this trial is testing

Dose-finding Study of ASP2151 in Subjects With Herpes Zoster

Who this might be right for
Herpes Zoster
Astellas Pharma Inc 403
Early research (Phase 1)Study completedNCT01460719
What this trial is testing

Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 80
Not applicableUnknownNCT03509701
What this trial is testing

Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus

Who this might be right for
Reversible Cerebral Vasoconstriction SyndromeVaricella-zoster Virus Infection
Asan Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT00099528
What this trial is testing

Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia

Who this might be right for
NeuralgiaShinglesPeripheral Nervous System Disease
Renovis 90
Post-approval studies (Phase 4)Study completedNCT03809702
What this trial is testing

Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia

Who this might be right for
Herpes Zoster
B.P. Koirala Institute of Health Sciences 82
Large-scale testing (Phase 3)Study completedNCT01827839
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster

Who this might be right for
Herpes Zoster
GlaxoSmithKline 96
Large-scale testing (Phase 3)Study completedNCT01527370
What this trial is testing

Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)

Who this might be right for
Herpes ZosterShingles
Merck Sharp & Dohme LLC 250
Testing effectiveness (Phase 2)Study completedNCT00092404
What this trial is testing

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,210
Large-scale testing (Phase 3)Study completedNCT03843632
What this trial is testing

Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)

Who this might be right for
Varicella
Merck Sharp & Dohme LLC 150
Large-scale testing (Phase 3)Study completedNCT05150392
What this trial is testing

An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

Who this might be right for
Varicella
Sinovac (Dalian) Vaccine Technology Co., Ltd. 1,193
Testing effectiveness (Phase 2)Looking for participantsNCT05580458
What this trial is testing

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Who this might be right for
Herpes Zoster
National Institute of Allergy and Infectious Diseases (NIAID) 225
Large-scale testing (Phase 3)Study completedNCT00377598
What this trial is testing

Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia

Who this might be right for
Neuralgia, Postherpetic
Takeda 399
Testing effectiveness (Phase 2)Study completedNCT00353288
What this trial is testing

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Who this might be right for
VaricellaRubellaMeasles+1 more
GlaxoSmithKline 446
Large-scale testing (Phase 3)Looking for participantsNCT07415252
What this trial is testing

SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years

Who this might be right for
Varicella (Chickenpox)
SK Bioscience Co., Ltd. 780
Not applicableLooking for participantsNCT04471493
What this trial is testing

Pediatric and Ambulatory Research in Infectious Diseases

Who this might be right for
OtitisBronchiolitisInfluenza+4 more
Association Clinique Thérapeutique Infantile du val de Marne 400,000
Large-scale testing (Phase 3)Study completedNCT00969436
What this trial is testing

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Who this might be right for
VaricellaRubellaMumps+1 more
GlaxoSmithKline 450
Not applicableStudy completedNCT05094687
What this trial is testing

Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).

Who this might be right for
Cutaneous ManifestationsSkin ManifestationsCOVID-19+5 more
Jinnah Postgraduate Medical Centre 1,206
Post-approval studies (Phase 4)Ended earlyNCT02408159
What this trial is testing

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Who this might be right for
Psoriasis
Innovaderm Research Inc. 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT07311148
What this trial is testing

A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older

Who this might be right for
Herpes Zoster (HZ)ShinglesVZV+1 more
Guangzhou Patronus Biotech Co., Ltd. 840
Next Page